Beraprost Sodium Tablet is not generally used in the treatment of kidney disease, its main application is to improve the chronic arterial occlusive disease caused by ulcers, intermittent claudication, pain and coldness and other symptoms, it is recommended to follow the doctor’s instructions to use the drug. Pepstatin Sodium Tablet mainly has the effect of antiplatelet and vasodilatation, increase blood flow, often applied to improve the chronic arterial occlusive disease caused by intermittent claudication, ulcers, pain and cold sensation and other symptoms, is generally not applicable to the treatment of kidney disease. Adverse drug reactions include rash, headache, dizziness, nausea, diarrhea, abdominal pain, loss of appetite, bleeding tendency, shock, and interstitial pneumonia. It is contraindicated in patients with bleeding associated with upper gastrointestinal bleeding, hemoptysis, fundus hemorrhage, urinary bleeding, hemophilia, capillary fragility and other conditions, and in women who are pregnant or may become pregnant. Precautions: Caution should be exercised in patients who are using anticoagulants, antiplatelet agents, thrombolytic agents; women during menstruation; patients with bleeding tendency and its factors. It is recommended that specific medication should be administered under the guidance of a specialist.